Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
AlgiPharma AS logo — A biopharmaceutical company with a focus on developing its f...

AlgiPharma AS

A biopharmaceutical company with a focus on developing its first drug candidate for patients with Cystic Fibrosis

Founded 2006 Norway Norway 8 employees Biotechnology, Pharmaceutical

General Information

Company Name AlgiPharma AS
Founded Year 2006
Location Norway Norway
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with AlgiPharma AS. To contact AlgiPharma AS, visit algipharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AlgiPharma AS compare?

A PDF of AlgiPharma AS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AlgiPharma AS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AlgiPharma AS

AlgiPharma, a biopharmaceutical company based in Norway, was founded in 2006 with a slogan of "A biopharmaceutical company with a focus on developing its first drug candidate for patients with Cystic Fibrosis." The company specializes in developing its proprietary alginate technology for drug delivery in various forms such as nanoparticles, small and large molecule based drugs, drug conjugates, and standalone API for diseases including cystic fibrosis, COPD, and infectious diseases. With expertise in addressing unmet medical needs, AlgiPharma boasts pharmaceutical scale production capabilities, protected by a broad family of patents. AlgiPharma's innovative alginate technology targets diseases characterized by abnormal mucus accumulation, non-invasive drug delivery challenges, microbial infection, biofilm formation, and antibiotic resistance. Despite no recent investment or disclosed investors, the company's focus on addressing critical medical needs through cutting-edge technology positions it as an attractive opportunity for potential venture capital allocation. This aligns with the industry's heightened interest in biotechnology and pharmaceuticals, making AlgiPharma a potential contender for attracting investment in the future.

Business keywords: biopharmaceutical company, drug delivery platform, alginate technology, drug candidate, Cystic Fibrosis, pharmaceutical production, patent protection, clinical stage, therapeutic innovation, nanoparticle delivery, antibiotic resistance, Norwegian biotech, national and international collaboration

No funding data available for AlgiPharma AS yet.

AlgiPharma AS Alternatives & Competitors

View All Alternatives
AlgiPharma AS vs
Allecra Therapeutics
Allecra Therapeutics

Our Mission: Answering the call to action to fight antibiotic resistance

Series B
7 employees
Biopharma, Biotechnology
AlgiPharma AS vs
Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. United States

We are a clinical-stage biopharmaceutical company dedicated to bringing novel treatments to people w...

Post-IPO Equity
25 employees
Biotechnology, Health Care
AlgiPharma AS vs
Santaris Pharma
Santaris Pharma

Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse disease states.

Venture round
Biotechnology, Health Care
View all alternatives

FAQ About AlgiPharma AS

A biopharmaceutical company with a focus on developing its first drug candidate for patients with Cystic Fibrosis
AlgiPharma AS was founded in 2006.
AlgiPharma AS is headquartered in Norway.
AlgiPharma AS operates in Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical company, drug delivery platform, alginate technology and drug candidate.
AlgiPharma AS has approximately 8 employees.
Top alternatives and competitors to AlgiPharma AS include Allecra Therapeutics, Satsuma Pharmaceuticals, Inc., Santaris Pharma, Cinclus Pharma, Microbion Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AlgiPharma AS and Allecra Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AlgiPharma AS, https://bouncewatch.com/company/algipharma, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes